Biocontainment Units by Odulair


Biocontainment Units such as those patented by Odulair were designed for use in both US hospitals and worldwide medical institutions to address highly contagious airborne viruses, including, Ebola SARS, among others. Odulair Ebola Isolation Unit has received the attention of the international press including an article on UK's The Economist.


Ebola Isolation Unit designed by Odulair
has been featured on the international press, including
UK's premier business publication, The Economist


Biocontainment Units by Odulair,
developed to address Ebola Virus Outbreak,
as featured by
The Economist




Popular Posts